1-9 of 9
Alejandro A. Gru
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lacutamab in Patients with Relapsed and/or Refractory Sézary Syndrome: Translational Analysis from the Tellomak Phase 2 Trial

Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Martine Bagot, Youn-H H. Kim, Larisa J Geskin, Pablo L Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Lubomir Sokol, Marie Beylot-Barry, Stéphane Dalle, Eric D. Jacobsen, Frederick Lansigan, Caroline Ram-Wolff, Michael S. Khodadoust, Pier Luigi Zinzani, Julien Viotti, David Magrez, Agnes Boyer Chammard, Constance Vagne, Flavien Carraguel, Laura Assante Miranda, Valentine Peri, Sivan Bokobza, Marie-Laure Thibult, Cécile Bonnafous, Florent Carrette, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1609.
https://doi.org/10.1182/blood-2024-200587
Published: 2024
Journal Articles

The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study

Andrew L. Feldman, Guangzhen Hu, Surendra Dasari, Lisa M. Rimsza, David W. Scott, Jimena B. Gimenez, Farah M. Salama, Min Shi, Elías Campo, Wing Chung Chan, James R. Cook, Giorgio Inghirami, Elaine S. Jaffe, Ryan Morin, Phillipp W. Raess, Andreas Rosenwald, Kerry J. Savage, Louis M. Staudt, George W. Wright, Catalina Amador, Jan Delabie, Timothy C. Greiner, Javeed Iqbal, Laura K. Hilton, Sarah L. Ondrejka, German Ott, Stefania Pittaluga, Graham W. Slack, Susan L. Slager, Joo Y. Song, Hao-Wei Wang, Ahmed A. Aljudi, Stephen M. Ansell, Carlos Barrionuevo, James R. Cerhan, Jennifer R. Chapman-Fredricks, Weina Chen, Laurence de Leval, Alejandro A. Gru, David L. Jaye, Liuyan Jiang, Brad S. Kahl, Kennosuke Karube, Young Hyeh Ko, Eric Mou, Matthew J. Maurer, L. Jeffrey Medeiros, Roberto N. Miranda, Naoki Oishi, Perry M. Anamarija, Akira Satou, Xueju Wang, Ryan A. Wilcox, Xiaojun Wu, Tadashi Yoshino, Yu Zeng
Journal: Blood
Blood (2024) 144 (Supplement 1): 2974.
https://doi.org/10.1182/blood-2024-202410
Published: 2024
Journal Articles

Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial

Martine Bagot, Youn H. Kim, Caroline Ram-Wolff, Stéphane Dalle, Neha Mehta-Shah, Auris O Huen, Brian Poligone, Pier Luigi Zinzani, Larisa J Geskin, Anne-Bénédicte Duval-Modeste, Pablo L Ortiz-Romero, Lubomir Sokol, Sherida Woei-A-Jin, Marie Beylot-Barry, Olivier Dereure, Michael S. Khodadoust, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Julien Viotti, Christine Paiva, Agnes Boyer Chammard, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 466.
https://doi.org/10.1182/blood-2024-194796
Published: 2024
Journal Articles

Lacutamab in Patients with Relapsed and Refractory Sèzary Syndrome: Results from the Tellomak Phase 2 Trial

Martine Bagot, Youn H. Kim, Larisa J. Geskin, Pablo L. Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Marie Beylot-Barry, Stéphane Dalle, Eric Jacobsen, Frederick Lansigan, Caroline Ram-Wolff, Michael S Khodadoust, Maxime Battistella, Alejandro A Gru, Hélène Moins-Teisserenc, Pier Luigi Zinzani, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Journal: Blood
Blood (2023) 142 (Supplement 1): 185.
https://doi.org/10.1182/blood-2023-173806
Published: 2023
Journal Articles

Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial

Martine Bagot, Youn H. Kim, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Neha Mehta-Shah, Olivier Dereure, Marie Beylot-Barry, Stéphane Dalle, Eric D Jacobsen, Auris Huen, Andrea Combalia, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Michael S. Khodadoust, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3760–3761.
https://doi.org/10.1182/blood-2022-160239
Published: 2022
Journal Articles

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Katie Lee, Mark G. Evans, Lei Yang, Spencer Ng, Caroline Snowden, Michael Khodadoust, Ryanne A. Brown, Nicholas A. Trum, Christiane Querfeld, Linda T. Doan, Jinming Song, Hailing Zhang, Alejandro A. Gru, Gary S. Wood, David A. Wada, Vignesh Shanmugam, Paul L. Haun, Jon C. Aster, Lyn M. Duncan, Joan Guitart, David M. Weinstock, Valentina Nardi, Jaehyuk Choi
Journal: Blood
Blood (2021) 138 (23): 2435–2440.
https://doi.org/10.1182/blood.2021012536
Published: 2021
Includes: Supplemental data
Journal Articles

Superior Clinical Benefit of Brentuximab Vedotin in Mycosis Fungoides Versus Physician's Choice Irrespective of CD30 Level or Large Cell Transformation Status in the Phase 3 ALCANZA Study

Youn H. Kim, MD, H. Miles Prince, MD FRACP, FRCPA, Sean Whittaker, MB, ChB, FRCP, MD, Steven M. Horwitz, MD, Madeleine Duvic, MD, Oliver Bechter, Jose A. Sanches, Rudolf Stadler, MD, Julia Scarisbrick, MD FRCP, MBBS, Pietro Quaglino, MD, Pier Luigi Zinzani, MD, Pascal Wolter, MD, Herbert Eradat, MD, Lauren C. Pinter-Brown, MD, Pablo L. Ortiz-Romero, Oleg E. Akilov, MD, Judith Trotman, FRACP, Kerry Taylor, Michael Weichenthal, MD, Jan Walewski, MD, David C. Fisher, MD PhD, Marise McNeeley, Alejandro A. Gru, MD, Yinghui Wang, MS, Maria Corinna Palanca-Wessels, MD PhD, Julie Lisano, Martha Li, Hui-Min Lin, PhD, Meredith Little, MPH, William L. Trepicchio, PhD, Reinhard Dummer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1646.
https://doi.org/10.1182/blood-2018-99-112847
Published: 2018
Journal Articles

Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)

Steven M. Horwitz, MD, Julia J. Scarisbrick, MD FRCP, MBBS †, Reinhard Dummer, MD, Madeleine Duvic, MD, Youn H. Kim, MD, Jan Walewski, MD, Sean Whittaker, MB, ChB, FRCP, MD, Pietro Quaglino, MD, Pier Luigi Zinzani, MD, Pascal Wolter, MD, Herbert Eradat, MD, Jose A. Sanches, PhD, Pablo L. Ortiz-Romero, MD PhD, Oleg E. Akilov, MD, Judith Trotman, FRACP, Kerry Taylor, FRACP,FRCPA,MBBS, Stephane Dalle, MD PhD, Michael Weichenthal, MD, David C. Fisher, MD, Rudolf Stadler, MD, Tatyana A Feldman, MD, Timothy M. Kuzel, MD, Alejandro A. Gru, MD, Yinghui Wang, MS, Maria Corinna Palanca-Wessels, MD PhD, Hui-Min Lin, PhD, Yi Liu, PhD, Meredith Little, MPH, H. Miles Prince, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1509.
https://doi.org/10.1182/blood.V130.Suppl_1.1509.1509
Published: 2017
Journal Articles

Therapeutic Efficacy of Mcl-1 Antagonism in Large Granular Lymphocyte Leukemia

Francis R LeBlanc, PhD, Jun Yang, MD, John H Heller, B.S., Shubha Dighe, M.S., Alejandro A. Gru, MD, Marya Dunlap-Brown, M.S., Hong-Gang Wang, PhD, David J Feith, PhD, Thomas P Loughran, Jr., MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1217.
https://doi.org/10.1182/blood.V130.Suppl_1.1217.1217
Published: 2017